Immunodeficiency refers to inadequate immune function that reduces the body's ability to prevent or control infections and, in some cases, increases susceptibility to particular cancers or other complications. Immunodeficiencies may be primary, resulting from genetic or developmental abnormalities, or secondary, resulting from acquired conditions, medicines, infections, malnutrition, malignancy, or other factors. The clinical consequences depend strongly on which part of the immune system is affected.
Defects involving antibodies predispose particularly to certain bacterial infections, while T-cell deficiencies can cause susceptibility to viral, fungal, protozoal, and opportunistic infections. Defects in phagocytes or complement produce different characteristic patterns. Immunodeficiency is therefore not one uniform disorder but a broad category covering numerous defects in immune development, regulation, signalling, or effector function.
Primary Immunodeficiencies, increasingly described in specialist medicine as inborn errors of immunity, result from inherited or de novo genetic abnormalities affecting immune pathways. They can involve B cells, T cells, natural killer cells, phagocytes, complement, innate immune signalling, or immune regulation. Some are apparent during infancy with severe or recurrent infections, whereas others present later with unusual infections, autoimmune disease, inflammation, or malignancy.
Severe combined immunodeficiency is a group of disorders in which T-cell function is profoundly impaired and other immune compartments may also be affected. Selective antibody deficiencies can produce a more specific pattern of recurrent respiratory infections. Genetic diagnosis has substantially expanded recognition of these disorders and has revealed that some immune defects produce both immunodeficiency and autoimmunity rather than a simple failure of immunity.
Secondary Immunodeficiencies are acquired and are substantially more common than many rare primary disorders. Causes include medicines such as corticosteroids, chemotherapy, immunosuppressive biological therapies, certain infections, haematological cancers, protein loss, severe malnutrition, and conditions that damage immune organs or cells. HIV infection can cause progressive impairment of CD4 T-cell function and increase susceptibility to opportunistic infections when untreated or inadequately controlled. The degree and type of immune suppression vary according to the cause, dose, duration, and affected immune pathway. Identifying an acquired cause is important because treating or removing the underlying factor may improve immune function. A person receiving deliberate immunosuppression for transplantation or autoimmune disease can therefore have predictable, treatment-related immunodeficiency without having a primary genetic disorder.
The infection pattern can provide clues about the underlying immune defect. Recurrent bacterial respiratory infections can suggest antibody deficiency, whereas persistent viral, fungal, or opportunistic infections may point towards T-cell or combined immune dysfunction. Deep abscesses and unusual bacterial infections can occur with phagocyte disorders, while recurrent Neisseria infections can be associated with certain complement deficiencies. However, these patterns are not absolute and overlap occurs.
Severity, age at onset, organisms involved, anatomical sites, response to standard treatment, family history, and associated autoimmune or inflammatory features all contribute to clinical assessment. An infection occurring repeatedly does not automatically establish immunodeficiency because exposure, anatomy, chronic disease, and other non-immune factors can also produce recurrent infections.
Investigation can include full blood counts, lymphocyte subsets, quantitative immunoglobulins, vaccine-specific antibody responses, complement studies, neutrophil function tests, HIV testing where appropriate, and specialised genetic or functional assays. The correct investigation depends on the suspected immune compartment. A normal total white-cell count does not exclude significant immunodeficiency because immune dysfunction can occur despite normal cell numbers. Similarly, a normal immunoglobulin concentration does not necessarily establish normal antibody function. Functional testing can therefore be as important as measuring the quantity of immune components. Genetic testing can identify pathogenic variants in selected patients, although interpretation requires specialist expertise because not every detected genetic variant causes disease.
Management depends on the immune defect and may include infection prevention, vaccination strategies, antimicrobial prophylaxis, immunoglobulin replacement, targeted medicines, or haematopoietic stem-cell transplantation for selected severe disorders. Live vaccines may be inappropriate for some individuals with significant immunodeficiency because attenuated organisms can cause disease in severely immunocompromised hosts. Immunoglobulin replacement can provide passive antibodies to selected patients with clinically significant antibody-production defects. Haematopoietic stem-cell transplantation can potentially provide a functioning immune system in certain severe inherited disorders, particularly when undertaken before irreversible infection or organ damage develops. Modern genetic and cellular therapies are expanding treatment possibilities for some rare immune disorders.
Immunodeficiency can increase infection risk, but the relationship is not simply proportional to the total number of infections. Specific immune defects create specific vulnerabilities, and some individuals may present predominantly with autoimmunity, inflammatory disease, lymphoproliferation, or malignancy. Conversely, frequent infections in childhood are often caused by ordinary exposure to common pathogens and do not necessarily indicate an immune disorder. Assessment therefore considers whether infections are unusually severe, persistent, recurrent in characteristic patterns, caused by unusual organisms, or associated with poor responses to appropriate treatment. Nutrition, sleep, anatomical abnormalities, chronic respiratory disease, and environmental exposure can also influence infection frequency independently of immune deficiency.
Immunodeficiency differs from Autoimmunity because the former involves inadequate immune defence, while the latter involves inappropriate immune recognition of self, although some disorders can involve both. It also differs from temporary immune suppression following an ordinary infection because immunodeficiency implies a clinically meaningful defect or reduction in immune function. The modern classification of immunodeficiencies has evolved substantially through immunology, genetics, flow cytometry, molecular diagnostics, and improved recognition of secondary causes.
A common misconception is that immunodeficiency always means having no immune response; many patients retain substantial immune function but have a selective defect. Accurate understanding therefore requires identifying which immune component is impaired, why it is impaired, what infections or complications result, and whether the defect is inherited, acquired, temporary, or persistent.
